India's pharma market is posed to double by 2030, to hit USD 120 bn - ET Manufacturing

Retrieved on: 2024-11-29 08:55:25

Tags for this article:

Boston Consulting Group

Healthcare in India

Sun Pharma

India

Click the tags to see associated articles and topics

India's pharma market is posed to double by 2030, to hit USD 120 bn - ET Manufacturing. View article details on hiswai:

Summary

The article discusses the rapid growth of India's pharmaceutical market, highlighting "Last Mile Delivery" as crucial in healthcare expansion, with insights from Boston Consulting Group and Sun Pharma. It connects to Indian healthcare advancements and strategic market positioning.

Article found on: manufacturing.economictimes.indiatimes.com

View Original Article